collaboration with uae based subsidiary & novartis for a drug: biocon- dec 10
Published 8 years ago • 123 plays • Length 5:57Download video MP4
Download video MP3
Similar videos
-
3:45
novartis not joining the 'frenzy' of weight loss drugs, ceo says
-
3:05
u.s. biosecure act: what will be the impact on indian pharma cos? | n18v | cnbc tv18
-
2:38
biocon gets us fda adequacy letter for gliraglutide api | cnbc tv18
-
0:16
lung inflation in science lesson #science #teacher #biology
-
1:57
u.s. biosecure act: a game changer for indian pharma companies?
-
12:15
china's wuxi apptec in crosshairs of us draft biosecurity bill
-
6:12
novartis ceo: expect continued growth in 2023
-
8:27
investment in the unlisted entity will continue with headcount set to rise 10% this year:novartis ag
-
3:29
novartis generated $40 billion in innovative medicine sales, says ceo
-
2:05
ceo of swiss drugmaker novartis outlines some major industry trends for 2024
-
0:57
novartis global ceo vas narasimhan: ai's impact on pharma and clinical trial realities | n18s
-
6:54
spago nanomedical | interview | investing in life science 2024
-
2:25
taiwanese pager company provides clarity on supply of devices that exploded in lebanon | world news
-
6:25
abarceo pharma | interview | investing in life science 2024
-
4:46
annexin pharmaceuticals | interview | investing in life science 2024
-
1:49
saudi arabia’s pif revolutionizing e-mobility sector with $39bn investments | arab news
-
0:56
product review on the advantages of extend 180™ long-term absorbable synthetic implants (bvi)
-
0:28
novartis acquiring cancer drug developer morphosys for €2.7 billion
-
14:58
weight-loss drug ozempic a 'medical breakthrough', but we won't be driven by fomo: novartis ceo
-
4:17
novartis ceo: we expect our six key drugs to grow ahead of analyst expectations
-
1:03
novavax surges on $1.2 billion sanofi vaccine deal
-
3:40
serum group, featured on cnbc tv 18 - greatest brands & leaders 2023-24